379 related articles for article (PubMed ID: 15939760)
1. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation.
Brero A; Easwaran HP; Nowak D; Grunewald I; Cremer T; Leonhardt H; Cardoso MC
J Cell Biol; 2005 Jun; 169(5):733-43. PubMed ID: 15939760
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation.
Agarwal N; Hardt T; Brero A; Nowak D; Rothbauer U; Becker A; Leonhardt H; Cardoso MC
Nucleic Acids Res; 2007; 35(16):5402-8. PubMed ID: 17698499
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium.
Plachot C; Lelièvre SA
Exp Cell Res; 2004 Aug; 298(1):122-32. PubMed ID: 15242767
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ChRO1 facilitates ATRX/DAXX-dependent H3.3 deposition for transcription-associated heterochromatin reorganization.
Park J; Lee H; Han N; Kwak S; Lee HT; Kim JH; Kang K; Youn BH; Yang JH; Jeong HJ; Kang JS; Kim SY; Han JW; Youn HD; Cho EJ
Nucleic Acids Res; 2018 Dec; 46(22):11759-11775. PubMed ID: 30335163
[TBL] [Abstract][Full Text] [Related]
5. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
6. DNA CpG hypomethylation induces heterochromatin reorganization involving the histone variant macroH2A.
Ma Y; Jacobs SB; Jackson-Grusby L; Mastrangelo MA; Torres-Betancourt JA; Jaenisch R; Rasmussen TP
J Cell Sci; 2005 Apr; 118(Pt 8):1607-16. PubMed ID: 15784683
[TBL] [Abstract][Full Text] [Related]
7. MBD2 and MeCP2 regulate distinct transitions in the stage-specific differentiation of olfactory receptor neurons.
Macdonald JL; Verster A; Berndt A; Roskams AJ
Mol Cell Neurosci; 2010 May; 44(1):55-67. PubMed ID: 20188178
[TBL] [Abstract][Full Text] [Related]
8. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.
Chandler SP; Guschin D; Landsberger N; Wolffe AP
Biochemistry; 1999 Jun; 38(22):7008-18. PubMed ID: 10353812
[TBL] [Abstract][Full Text] [Related]
9. ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation.
Marano D; Fioriniello S; Fiorillo F; Gibbons RJ; D'Esposito M; Della Ragione F
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671722
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.
Klose RJ; Yamane K; Bae Y; Zhang D; Erdjument-Bromage H; Tempst P; Wong J; Zhang Y
Nature; 2006 Jul; 442(7100):312-6. PubMed ID: 16732292
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
[TBL] [Abstract][Full Text] [Related]
12. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
[TBL] [Abstract][Full Text] [Related]
13. Methyl CpG-binding proteins and transcriptional repression.
Wade PA
Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
[TBL] [Abstract][Full Text] [Related]
14. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
Bapat S; Galande S
Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1.
Kourmouli N; Sun YM; van der Sar S; Singh PB; Brown JP
Biochem Biophys Res Commun; 2005 Nov; 337(3):901-7. PubMed ID: 16213461
[TBL] [Abstract][Full Text] [Related]
16. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells.
Koch C; Strätling WH
Biochemistry; 2004 May; 43(17):5011-21. PubMed ID: 15109260
[TBL] [Abstract][Full Text] [Related]
17. The solution structure of the domain from MeCP2 that binds to methylated DNA.
Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M
J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318
[TBL] [Abstract][Full Text] [Related]
19. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation.
Kaufmann WE; Jarrar MH; Wang JS; Lee YJ; Reddy S; Bibat G; Naidu S
Brain Dev; 2005 Aug; 27(5):331-9. PubMed ID: 16023547
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 and other methyl-CpG binding proteins.
Jørgensen HF; Bird A
Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
